Magnetic Resonance Imaging to Detect Cardiovascular Effects of Cancer Therapy: JACC CardioOncology State-of-the-Art Review
- PMID: 34396235
- PMCID: PMC8352317
- DOI: 10.1016/j.jaccao.2020.04.011
Magnetic Resonance Imaging to Detect Cardiovascular Effects of Cancer Therapy: JACC CardioOncology State-of-the-Art Review
Abstract
This paper aims to empower and inform cardio-oncologists by providing a practical guide to the clinical application of cardiac magnetic resonance (CMR) in the rapidly evolving field of cardio-oncology. Specifically, we describe how CMR can be used to assess the cardiovascular effects of cancer therapy. The CMR literature, relevant societal guidelines, indication-specific imaging protocols, and methods to overcome some of the challenges encountered in performing and accessing CMR are reviewed.
Keywords: CMR, cardiac magnetic resonance; ECV, extracellular volume fraction; EGE, early gadolinium enhancement; ICI, immune checkpoint inhibitors; LGE, late gadolinium enhancement; LVEF, left ventricular ejection fraction; MACE, major adverse cardiac event; SSFP, balanced steady state free precession; cardio-oncology; cardiotoxicity; cardiovascular magnetic resonance; chemotherapy; left ventricular dysfunction; tissue characterization.
© 2020 The Authors.
Figures













Similar articles
-
Cardiac Magnetic Resonance in Cardio-Oncology: Advantages, Importance of Expediency, and Considerations to Navigate Pre-Authorization.JACC CardioOncol. 2021 Jun 15;3(2):191-200. doi: 10.1016/j.jaccao.2021.04.011. eCollection 2021 Jun. JACC CardioOncol. 2021. PMID: 34396324 Free PMC article. Review.
-
Prognostic utility of differential tissue characterization of cardiac neoplasm and thrombus via late gadolinium enhancement cardiovascular magnetic resonance among patients with advanced systemic cancer.J Cardiovasc Magn Reson. 2017 Oct 12;19(1):76. doi: 10.1186/s12968-017-0390-2. J Cardiovasc Magn Reson. 2017. PMID: 29025425 Free PMC article.
-
Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging.JACC Cardiovasc Imaging. 2020 Nov;13(11):2330-2339. doi: 10.1016/j.jcmg.2020.05.004. Epub 2020 May 12. JACC Cardiovasc Imaging. 2020. PMID: 32763118 Free PMC article.
-
The prognostic value of global myocardium strain by CMR-feature tracking in immune checkpoint inhibitor-associated myocarditis.Eur Radiol. 2022 Nov;32(11):7657-7667. doi: 10.1007/s00330-022-08844-x. Epub 2022 May 14. Eur Radiol. 2022. PMID: 35567603
-
Cardiac MRI assessment of anthracycline-induced cardiotoxicity.Front Cardiovasc Med. 2022 Sep 27;9:903719. doi: 10.3389/fcvm.2022.903719. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36237899 Free PMC article. Review.
Cited by
-
Cardiovascular Imaging in Cardio-Oncology: The Role of Echocardiography and Cardiac MRI in Modern Cardio-Oncology.Heart Fail Clin. 2022 Jul;18(3):455-478. doi: 10.1016/j.hfc.2022.02.007. Heart Fail Clin. 2022. PMID: 35718419 Free PMC article. Review.
-
The Role of Advanced Cardiac Imaging in Monitoring Cardiovascular Complications in Patients with Extracardiac Tumors: A Descriptive Review.J Cardiovasc Dev Dis. 2024 Dec 29;12(1):9. doi: 10.3390/jcdd12010009. J Cardiovasc Dev Dis. 2024. PMID: 39852287 Free PMC article. Review.
-
Chemotherapy effect on myocardial fibrosis markers in patients with gynecologic cancer and low cardiovascular risk.Front Oncol. 2023 Aug 8;13:1173838. doi: 10.3389/fonc.2023.1173838. eCollection 2023. Front Oncol. 2023. PMID: 37614506 Free PMC article.
-
Applications of Artificial Intelligence for the Prediction and Diagnosis of Cancer Therapy-Related Cardiac Dysfunction in Oncology Patients.Cancers (Basel). 2025 Feb 11;17(4):605. doi: 10.3390/cancers17040605. Cancers (Basel). 2025. PMID: 40002200 Free PMC article. Review.
-
Adverse cardiovascular events and cardiac imaging findings in patients on immune checkpoint inhibitors.PLoS One. 2024 Dec 2;19(12):e0314555. doi: 10.1371/journal.pone.0314555. eCollection 2024. PLoS One. 2024. PMID: 39621799 Free PMC article.
References
-
- Zamorano J.L., Lancellotti P., Rodriguez Muñoz D. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC) Eur Heart J. 2016;37:2768–2801. - PubMed
-
- Doherty J.U., Kort S., Mehran R. ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 appropriate use criteria for multimodality imaging in the assessment of cardiac structure and function in nonvalvular heart disease: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2019;73:488–516. - PubMed
-
- Schulz-Menger J., Bluemke D.A., Bremerich J. Standardized image interpretation and post-processing in cardiovascular magnetic resonance — 2020 update: Society for Cardiovascular Magnetic Resonance (SCMR): Board of Trustees Task Force on Standardized Post-Processing. J Cardiovasc Magn Reson. 2020;22:19. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources